Biotechnology-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Biotechnology-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Biotechnology industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Biotechnology 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Biotechnology worldwide and market share by regions, with company and product introduction, position in the Biotechnology market
Market status and development trend of Biotechnology by types and applications
Cost and profit status of Biotechnology, and marketing status
Market growth drivers and challenges
The report segments the global Biotechnology market as:
Global Biotechnology Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Biotechnology Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA Sequencing
Nanobiotechnology
Tissue engineering and Regeneration
Fermentation
Cell Based Assay
PCR Technology
Chromatography Market
Others
Global Biotechnology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Health
Food & Agriculture
Natural Resources & Environment
Industrial Processing
Bioinformatics
Others
Global Biotechnology Market: Manufacturers Segment Analysis (Company and Product introduction, Biotechnology Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Pfizer
Merck & Co.
Sanofi
AstraZeneca
Gilead
CELGENE CORPORATION
Biogen
Amgen, Inc
Abbott
Novo Nordisk A/S
Novartis AG
Lonza
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Biotechnology-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Biotechnology industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Biotechnology 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Biotechnology worldwide and market share by regions, with company and product introduction, position in the Biotechnology market
Market status and development trend of Biotechnology by types and applications
Cost and profit status of Biotechnology, and marketing status
Market growth drivers and challenges
The report segments the global Biotechnology market as:
Global Biotechnology Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Biotechnology Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA Sequencing
Nanobiotechnology
Tissue engineering and Regeneration
Fermentation
Cell Based Assay
PCR Technology
Chromatography Market
Others
Global Biotechnology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Health
Food & Agriculture
Natural Resources & Environment
Industrial Processing
Bioinformatics
Others
Global Biotechnology Market: Manufacturers Segment Analysis (Company and Product introduction, Biotechnology Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Pfizer
Merck & Co.
Sanofi
AstraZeneca
Gilead
CELGENE CORPORATION
Biogen
Amgen, Inc
Abbott
Novo Nordisk A/S
Novartis AG
Lonza
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIOTECHNOLOGY
1.1 Definition of Biotechnology in This Report
1.2 Commercial Types of Biotechnology
1.2.1 DNA Sequencing
1.2.2 Nanobiotechnology
1.2.3 Tissue engineering and Regeneration
1.2.4 Fermentation
1.2.5 Cell Based Assay
1.2.6 PCR Technology
1.2.7 Chromatography Market
1.2.8 Others
1.3 Downstream Application of Biotechnology
1.3.1 Health
1.3.2 Food & Agriculture
1.3.3 Natural Resources & Environment
1.3.4 Industrial Processing
1.3.5 Bioinformatics
1.3.6 Others
1.4 Development History of Biotechnology
1.5 Market Status and Trend of Biotechnology 2013-2023
1.5.1 Global Biotechnology Market Status and Trend 2013-2023
1.5.2 Regional Biotechnology Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Biotechnology 2013-2017
2.2 Sales Market of Biotechnology by Regions
2.2.1 Sales Volume of Biotechnology by Regions
2.2.2 Sales Value of Biotechnology by Regions
2.3 Production Market of Biotechnology by Regions
2.4 Global Market Forecast of Biotechnology 2018-2023
2.4.1 Global Market Forecast of Biotechnology 2018-2023
2.4.2 Market Forecast of Biotechnology by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Biotechnology by Types
3.2 Sales Value of Biotechnology by Types
3.3 Market Forecast of Biotechnology by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Biotechnology by Downstream Industry
4.2 Global Market Forecast of Biotechnology by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Biotechnology Market Status by Countries
5.1.1 North America Biotechnology Sales by Countries (2013-2017)
5.1.2 North America Biotechnology Revenue by Countries (2013-2017)
5.1.3 United States Biotechnology Market Status (2013-2017)
5.1.4 Canada Biotechnology Market Status (2013-2017)
5.1.5 Mexico Biotechnology Market Status (2013-2017)
5.2 North America Biotechnology Market Status by Manufacturers
5.3 North America Biotechnology Market Status by Type (2013-2017)
5.3.1 North America Biotechnology Sales by Type (2013-2017)
5.3.2 North America Biotechnology Revenue by Type (2013-2017)
5.4 North America Biotechnology Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Biotechnology Market Status by Countries
6.1.1 Europe Biotechnology Sales by Countries (2013-2017)
6.1.2 Europe Biotechnology Revenue by Countries (2013-2017)
6.1.3 Germany Biotechnology Market Status (2013-2017)
6.1.4 UK Biotechnology Market Status (2013-2017)
6.1.5 France Biotechnology Market Status (2013-2017)
6.1.6 Italy Biotechnology Market Status (2013-2017)
6.1.7 Russia Biotechnology Market Status (2013-2017)
6.1.8 Spain Biotechnology Market Status (2013-2017)
6.1.9 Benelux Biotechnology Market Status (2013-2017)
6.2 Europe Biotechnology Market Status by Manufacturers
6.3 Europe Biotechnology Market Status by Type (2013-2017)
6.3.1 Europe Biotechnology Sales by Type (2013-2017)
6.3.2 Europe Biotechnology Revenue by Type (2013-2017)
6.4 Europe Biotechnology Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Biotechnology Market Status by Countries
7.1.1 Asia Pacific Biotechnology Sales by Countries (2013-2017)
7.1.2 Asia Pacific Biotechnology Revenue by Countries (2013-2017)
7.1.3 China Biotechnology Market Status (2013-2017)
7.1.4 Japan Biotechnology Market Status (2013-2017)
7.1.5 India Biotechnology Market Status (2013-2017)
7.1.6 Southeast Asia Biotechnology Market Status (2013-2017)
7.1.7 Australia Biotechnology Market Status (2013-2017)
7.2 Asia Pacific Biotechnology Market Status by Manufacturers
7.3 Asia Pacific Biotechnology Market Status by Type (2013-2017)
7.3.1 Asia Pacific Biotechnology Sales by Type (2013-2017)
7.3.2 Asia Pacific Biotechnology Revenue by Type (2013-2017)
7.4 Asia Pacific Biotechnology Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Biotechnology Market Status by Countries
8.1.1 Latin America Biotechnology Sales by Countries (2013-2017)
8.1.2 Latin America Biotechnology Revenue by Countries (2013-2017)
8.1.3 Brazil Biotechnology Market Status (2013-2017)
8.1.4 Argentina Biotechnology Market Status (2013-2017)
8.1.5 Colombia Biotechnology Market Status (2013-2017)
8.2 Latin America Biotechnology Market Status by Manufacturers
8.3 Latin America Biotechnology Market Status by Type (2013-2017)
8.3.1 Latin America Biotechnology Sales by Type (2013-2017)
8.3.2 Latin America Biotechnology Revenue by Type (2013-2017)
8.4 Latin America Biotechnology Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Biotechnology Market Status by Countries
9.1.1 Middle East and Africa Biotechnology Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Biotechnology Revenue by Countries (2013-2017)
9.1.3 Middle East Biotechnology Market Status (2013-2017)
9.1.4 Africa Biotechnology Market Status (2013-2017)
9.2 Middle East and Africa Biotechnology Market Status by Manufacturers
9.3 Middle East and Africa Biotechnology Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Biotechnology Sales by Type (2013-2017)
9.3.2 Middle East and Africa Biotechnology Revenue by Type (2013-2017)
9.4 Middle East and Africa Biotechnology Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF BIOTECHNOLOGY
10.1 Global Economy Situation and Trend Overview
10.2 Biotechnology Downstream Industry Situation and Trend Overview
CHAPTER 11 BIOTECHNOLOGY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Biotechnology by Major Manufacturers
11.2 Production Value of Biotechnology by Major Manufacturers
11.3 Basic Information of Biotechnology by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Biotechnology Major Manufacturer
11.3.2 Employees and Revenue Level of Biotechnology Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 BIOTECHNOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Johnson & Johnson Services, Inc.
12.1.1 Company profile
12.1.2 Representative Biotechnology Product
12.1.3 Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc.
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Company profile
12.2.2 Representative Biotechnology Product
12.2.3 Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd
12.3 Pfizer
12.3.1 Company profile
12.3.2 Representative Biotechnology Product
12.3.3 Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer
12.4 Merck & Co.
12.4.1 Company profile
12.4.2 Representative Biotechnology Product
12.4.3 Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co.
12.5 Sanofi
12.5.1 Company profile
12.5.2 Representative Biotechnology Product
12.5.3 Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi
12.6 AstraZeneca
12.6.1 Company profile
12.6.2 Representative Biotechnology Product
12.6.3 Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca
12.7 Gilead
12.7.1 Company profile
12.7.2 Representative Biotechnology Product
12.7.3 Biotechnology Sales, Revenue, Price and Gross Margin of Gilead
12.8 CELGENE CORPORATION
12.8.1 Company profile
12.8.2 Representative Biotechnology Product
12.8.3 Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION
12.9 Biogen
12.9.1 Company profile
12.9.2 Representative Biotechnology Product
12.9.3 Biotechnology Sales, Revenue, Price and Gross Margin of Biogen
12.10 Amgen, Inc
12.10.1 Company profile
12.10.2 Representative Biotechnology Product
12.10.3 Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc
12.11 Abbott
12.11.1 Company profile
12.11.2 Representative Biotechnology Product
12.11.3 Biotechnology Sales, Revenue, Price and Gross Margin of Abbott
12.12 Novo Nordisk A/S
12.12.1 Company profile
12.12.2 Representative Biotechnology Product
12.12.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
12.13 Novartis AG
12.13.1 Company profile
12.13.2 Representative Biotechnology Product
12.13.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG
12.14 Lonza
12.14.1 Company profile
12.14.2 Representative Biotechnology Product
12.14.3 Biotechnology Sales, Revenue, Price and Gross Margin of Lonza
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOTECHNOLOGY
13.1 Industry Chain of Biotechnology
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF BIOTECHNOLOGY
14.1 Cost Structure Analysis of Biotechnology
14.2 Raw Materials Cost Analysis of Biotechnology
14.3 Labor Cost Analysis of Biotechnology
14.4 Manufacturing Expenses Analysis of Biotechnology
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Biotechnology in This Report
1.2 Commercial Types of Biotechnology
1.2.1 DNA Sequencing
1.2.2 Nanobiotechnology
1.2.3 Tissue engineering and Regeneration
1.2.4 Fermentation
1.2.5 Cell Based Assay
1.2.6 PCR Technology
1.2.7 Chromatography Market
1.2.8 Others
1.3 Downstream Application of Biotechnology
1.3.1 Health
1.3.2 Food & Agriculture
1.3.3 Natural Resources & Environment
1.3.4 Industrial Processing
1.3.5 Bioinformatics
1.3.6 Others
1.4 Development History of Biotechnology
1.5 Market Status and Trend of Biotechnology 2013-2023
1.5.1 Global Biotechnology Market Status and Trend 2013-2023
1.5.2 Regional Biotechnology Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Biotechnology 2013-2017
2.2 Sales Market of Biotechnology by Regions
2.2.1 Sales Volume of Biotechnology by Regions
2.2.2 Sales Value of Biotechnology by Regions
2.3 Production Market of Biotechnology by Regions
2.4 Global Market Forecast of Biotechnology 2018-2023
2.4.1 Global Market Forecast of Biotechnology 2018-2023
2.4.2 Market Forecast of Biotechnology by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Biotechnology by Types
3.2 Sales Value of Biotechnology by Types
3.3 Market Forecast of Biotechnology by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Biotechnology by Downstream Industry
4.2 Global Market Forecast of Biotechnology by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Biotechnology Market Status by Countries
5.1.1 North America Biotechnology Sales by Countries (2013-2017)
5.1.2 North America Biotechnology Revenue by Countries (2013-2017)
5.1.3 United States Biotechnology Market Status (2013-2017)
5.1.4 Canada Biotechnology Market Status (2013-2017)
5.1.5 Mexico Biotechnology Market Status (2013-2017)
5.2 North America Biotechnology Market Status by Manufacturers
5.3 North America Biotechnology Market Status by Type (2013-2017)
5.3.1 North America Biotechnology Sales by Type (2013-2017)
5.3.2 North America Biotechnology Revenue by Type (2013-2017)
5.4 North America Biotechnology Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Biotechnology Market Status by Countries
6.1.1 Europe Biotechnology Sales by Countries (2013-2017)
6.1.2 Europe Biotechnology Revenue by Countries (2013-2017)
6.1.3 Germany Biotechnology Market Status (2013-2017)
6.1.4 UK Biotechnology Market Status (2013-2017)
6.1.5 France Biotechnology Market Status (2013-2017)
6.1.6 Italy Biotechnology Market Status (2013-2017)
6.1.7 Russia Biotechnology Market Status (2013-2017)
6.1.8 Spain Biotechnology Market Status (2013-2017)
6.1.9 Benelux Biotechnology Market Status (2013-2017)
6.2 Europe Biotechnology Market Status by Manufacturers
6.3 Europe Biotechnology Market Status by Type (2013-2017)
6.3.1 Europe Biotechnology Sales by Type (2013-2017)
6.3.2 Europe Biotechnology Revenue by Type (2013-2017)
6.4 Europe Biotechnology Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Biotechnology Market Status by Countries
7.1.1 Asia Pacific Biotechnology Sales by Countries (2013-2017)
7.1.2 Asia Pacific Biotechnology Revenue by Countries (2013-2017)
7.1.3 China Biotechnology Market Status (2013-2017)
7.1.4 Japan Biotechnology Market Status (2013-2017)
7.1.5 India Biotechnology Market Status (2013-2017)
7.1.6 Southeast Asia Biotechnology Market Status (2013-2017)
7.1.7 Australia Biotechnology Market Status (2013-2017)
7.2 Asia Pacific Biotechnology Market Status by Manufacturers
7.3 Asia Pacific Biotechnology Market Status by Type (2013-2017)
7.3.1 Asia Pacific Biotechnology Sales by Type (2013-2017)
7.3.2 Asia Pacific Biotechnology Revenue by Type (2013-2017)
7.4 Asia Pacific Biotechnology Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Biotechnology Market Status by Countries
8.1.1 Latin America Biotechnology Sales by Countries (2013-2017)
8.1.2 Latin America Biotechnology Revenue by Countries (2013-2017)
8.1.3 Brazil Biotechnology Market Status (2013-2017)
8.1.4 Argentina Biotechnology Market Status (2013-2017)
8.1.5 Colombia Biotechnology Market Status (2013-2017)
8.2 Latin America Biotechnology Market Status by Manufacturers
8.3 Latin America Biotechnology Market Status by Type (2013-2017)
8.3.1 Latin America Biotechnology Sales by Type (2013-2017)
8.3.2 Latin America Biotechnology Revenue by Type (2013-2017)
8.4 Latin America Biotechnology Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Biotechnology Market Status by Countries
9.1.1 Middle East and Africa Biotechnology Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Biotechnology Revenue by Countries (2013-2017)
9.1.3 Middle East Biotechnology Market Status (2013-2017)
9.1.4 Africa Biotechnology Market Status (2013-2017)
9.2 Middle East and Africa Biotechnology Market Status by Manufacturers
9.3 Middle East and Africa Biotechnology Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Biotechnology Sales by Type (2013-2017)
9.3.2 Middle East and Africa Biotechnology Revenue by Type (2013-2017)
9.4 Middle East and Africa Biotechnology Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF BIOTECHNOLOGY
10.1 Global Economy Situation and Trend Overview
10.2 Biotechnology Downstream Industry Situation and Trend Overview
CHAPTER 11 BIOTECHNOLOGY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Biotechnology by Major Manufacturers
11.2 Production Value of Biotechnology by Major Manufacturers
11.3 Basic Information of Biotechnology by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Biotechnology Major Manufacturer
11.3.2 Employees and Revenue Level of Biotechnology Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 BIOTECHNOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Johnson & Johnson Services, Inc.
12.1.1 Company profile
12.1.2 Representative Biotechnology Product
12.1.3 Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc.
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Company profile
12.2.2 Representative Biotechnology Product
12.2.3 Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd
12.3 Pfizer
12.3.1 Company profile
12.3.2 Representative Biotechnology Product
12.3.3 Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer
12.4 Merck & Co.
12.4.1 Company profile
12.4.2 Representative Biotechnology Product
12.4.3 Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co.
12.5 Sanofi
12.5.1 Company profile
12.5.2 Representative Biotechnology Product
12.5.3 Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi
12.6 AstraZeneca
12.6.1 Company profile
12.6.2 Representative Biotechnology Product
12.6.3 Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca
12.7 Gilead
12.7.1 Company profile
12.7.2 Representative Biotechnology Product
12.7.3 Biotechnology Sales, Revenue, Price and Gross Margin of Gilead
12.8 CELGENE CORPORATION
12.8.1 Company profile
12.8.2 Representative Biotechnology Product
12.8.3 Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION
12.9 Biogen
12.9.1 Company profile
12.9.2 Representative Biotechnology Product
12.9.3 Biotechnology Sales, Revenue, Price and Gross Margin of Biogen
12.10 Amgen, Inc
12.10.1 Company profile
12.10.2 Representative Biotechnology Product
12.10.3 Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc
12.11 Abbott
12.11.1 Company profile
12.11.2 Representative Biotechnology Product
12.11.3 Biotechnology Sales, Revenue, Price and Gross Margin of Abbott
12.12 Novo Nordisk A/S
12.12.1 Company profile
12.12.2 Representative Biotechnology Product
12.12.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
12.13 Novartis AG
12.13.1 Company profile
12.13.2 Representative Biotechnology Product
12.13.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG
12.14 Lonza
12.14.1 Company profile
12.14.2 Representative Biotechnology Product
12.14.3 Biotechnology Sales, Revenue, Price and Gross Margin of Lonza
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOTECHNOLOGY
13.1 Industry Chain of Biotechnology
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF BIOTECHNOLOGY
14.1 Cost Structure Analysis of Biotechnology
14.2 Raw Materials Cost Analysis of Biotechnology
14.3 Labor Cost Analysis of Biotechnology
14.4 Manufacturing Expenses Analysis of Biotechnology
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
